Blog FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer November 9, 2018December 14, 2022 Arthur N. Brodsky, PhD
Blog First Checkpoint Immunotherapy Approved for Advanced Cervical Cancer June 13, 2018December 14, 2022 Arthur N. Brodsky, PhD
Blog Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer February 20, 2018December 14, 2022 Arthur N. Brodsky, PhD